Navigation Links
Infinata’s BioPharm Insight to Offer Exclusive Preview of 2013 Key Reports at the BIO International Conference and Partnerships in Clinical Trials

Norwood, MA (PRWEB) April 19, 2013

BioPharm Insight(TM), Infinata’s flagship intelligence solution for the global biopharmaceutical community, will be active participants the upcoming BIO International Conference and the 22nd Annual Partnerships in Clinical Trials conference this month, with an exclusive preview of key reports for 2013:

May Catalyst Monitor highlights significant upcoming catalysts, including:

  • Difficulties AVEO’s tivozanib might face if approved for advanced renal cell carcinoma
  • Whether Delcath’s Melblez progression-free survival data is sufficient enough for US approval
  • Nektar Therapeutic’s NKTR-118 in opioid-induced constipation

CRO/CMO Quarterly Report analyzes clinical study activity across the globe. Included within the report is clinical activity by region and country, therapeutic area, and site activity. One trend reported was a drop in the number of clinical trials and the number of enrolled patients in the first quarter of 2013 compared to the first quarter of 2012.

Orphan Drugs Report discusses the top global trends within the orphan disease space, including forward-looking editorial coverage on:

  • Amicus’ and BioMarin’s drug candidates for Pompe disease
  • Xenikos co-development discussions for orphan GVHD drug
  • Case-by-case reimbursement for Aegerion’s Juxtapid and Sanofi/Isis’ Kynamro

Post-ACC Report summarizing our editorial team’s coverage of the American College of Cardiology Meeting. Significant industry topics include:

  • Portola’s betrixaban faces comparison to past failures and possibility for safety issues in ongoing Phase III APEX study
  • Experts views on Bayer and J&J’s plans to pursue anticoagulant Xarelto in coronary artery disease and chronic heart failure
  • Merck’s vorapaxar approval chances in myocardial infarction

To learn how BioPharm Insight can help you find new business opportunities, stop by booth #210 at Partnerships in Clinical Trials for an onsite demo or start your free trial today. Gain access to all the data, analytics and intelligence mentioned in this news release.

About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit Follow BioPharm Insight on LinkedIn and Twitter.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Galien Foundation Appoints Kimberly Ha of Infinata’s BioPharm Insight to US Advisory Board
2. Infinata’s BioPharm Insight Gears Up for the 2013 American College of Cardiology Meeting with the Release of its Cardiovascular Diseases Report
3. Infinata’s BioPharm Insight Releases Licensing League Tables Report for 4Q12 and YE12
4. Infinata’s BioPharm Insight Signs 200th Media Partner, Inaugurates Advertising Program
5. Infinata’s BioPharm Insight™ Achieves Record Growth in 2012
6. Infinata's BioPharm Insight Global Editor Kim Ha to Moderate Panel at 3rd Annual U.S.-China Conference on Strategies for Mining Profits from Pharma Opportunities in China
7. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
8. Infinata Implements “Clear Quality” Initiative to Optimize Reliability and Usability of Data, Reports and Analysis for Biopharma and Wealth Management Solutions
9. BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists
10. BioPharm Insight Releases its Catalyst Monitor for April 2013
11. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
Post Your Comments:
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
(Date:11/24/2015)... ... 2015 , ... The United States Golf Association (USGA) today announced Dr. Bruce ... Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
Breaking Biology Technology:
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... today announced that Google has adopted the Synaptics ® ... controller solutions to power its newest flagship smartphones, the ... Huawei. --> --> ... Google to provide strategic collaboration in the joint development ...
Breaking Biology News(10 mins):